|
|
Line 1: |
Line 1: |
| '''Non-small cell [[lung]] cancer''', abbreviated '''NSCLC''', is a malignant neoplasm of the lung that is ''not'' [[small cell carcinoma of the lung]].
| | #redirect [[Non-small cell lung carcinoma]] |
| | |
| It can be understood as a synonym for '''large cell carcinoma''' and '''non-small cell lung carcinoma'''. It is umbrella term that includes [[squamous cell carcinoma of lung]], [[adenocarcinoma of the lung]] and [[adenosquamous carcinoma of the lung]].<ref>{{Cite journal | last1 = Song | first1 = Z. | last2 = Lin | first2 = B. | last3 = Shao | first3 = L. | last4 = Zhang | first4 = Y. | title = Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma. | journal = J Chin Med Assoc | volume = 76 | issue = 9 | pages = 481-5 | month = Sep | year = 2013 | doi = 10.1016/j.jcma.2013.05.007 | PMID = 23769878 }}</ref>
| |
| | |
| ==General==
| |
| *''Non-small cell lung carcinoma'' can be considered a [[waffle diagnosis]] and as such its use should be limited.
| |
| **It is preferable to be more specific if this is possible, i.e. call ''adenocarcinoma'' or ''squamous cell carcinoma''.
| |
| *Historically, it was sufficient to differentiate between [[small cell carcinoma of the lung|small cell]] and non-small cell carcinomas, as the treatment for all non-small cell lung carcinomas was the same.
| |
| | |
| ==Microscopic==
| |
| Features:
| |
| *Large cells with abundant cytoplasm.
| |
| *+/-[[Nucleoli]].
| |
| *No stippled chromatin.
| |
| **This suggests the ''large cell variant of small cell carcinoma''.
| |
| | |
| DDx:
| |
| *[[Squamous cell carcinoma of the lung]].
| |
| *[[Adenocarcinoma of the lung]].
| |
| *[[Small cell carcinoma of the lung]].
| |
| *Large cell variant of [[small cell carcinoma of the lung]].
| |
| | |
| ==IHC==
| |
| Sloan-Kettering algorithm - Rekhtman ''et al.'':<ref name=pmid21623384>{{Cite journal | last1 = Rekhtman | first1 = N. | last2 = Ang | first2 = DC. | last3 = Sima | first3 = CS. | last4 = Travis | first4 = WD. | last5 = Moreira | first5 = AL. | title = Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. | journal = Mod Pathol | volume = 24 | issue = 10 | pages = 1348-59 | month = Oct | year = 2011 | doi = 10.1038/modpathol.2011.92 | PMID = 21623384 }}</ref>
| |
| {| class="wikitable sortable"
| |
| ! TTF-1\p63
| |
| ! p63 -ve (0% of cells)
| |
| ! p63 +ve <50% of cells
| |
| ! p63 +ve >=50% of cells
| |
| |-
| |
| | TTF-1 +ve >=50% of cells
| |
| | [[adenocarcinoma of the lung|Adenocarcinoma]]
| |
| | Adenocarcinoma
| |
| | Adenocarcinoma
| |
| |-
| |
| | TTF-1 +ve <50% of cells
| |
| | Adenocarcinoma
| |
| | Adenocarcinoma
| |
| | [[Lung SCC|Squamous carcinoma]]
| |
| |-
| |
| | TTF-1 -ve (0% of cells)
| |
| | Adenocarcinoma
| |
| | CK5/6 to determine
| |
| | Squamous carcinoma
| |
| |}
| |
| | |
| ==See also==
| |
| *[[Lung tumours]].
| |
| | |
| ==References==
| |
| {{Reflist|1}}
| |
| | |
| [[Category:Pulmonary pathology]]
| |